OBJECTIVE: To investigate multi-echo chemical shift-encoded MRI-based mapping of proton density fat fraction (PDFF) and fat-corrected R2* in bone marrow as biomarkers for osteoporosis assessment. METHODS: Fifty-one patients (28 female; mean age 69.7 ± 9.0 years) underwent dual energy X-ray absorptiometry (DXA). On the basis of the t score, 173 valid vertebrae bodies were divided into three groups (healthy, osteopenic and osteoporotic). Three echo chemical shift-encoded MRI sequences were acquired at 3 T. PDFF and R2* with correction for multiple-peak fat (R2*MP) were measured for each vertebral body. Kruskal-Wallis test and post hoc analysis were performed to evaluate differences between groups. Further, the area under the curve (AUC) for each technique was calculated using logistic regression analysis. RESULTS: On the basis of DXA, 92 samples were normal (53 %), 47 osteopenic (27 %) and 34 osteoporotic (20 %). PDFF was increased in osteoporosis compared with healthy (P = 0.007). R2*MP showed significant differences between normal and osteopenia (P = 0.004), and between normal and osteoporosis (P < 0.001). AUC to differentiate between normal and osteoporosis was 0.698 for R2*MP, 0.656 for PDFF and 0.74 for both combined. CONCLUSION: PDFF and R2*MP are moderate biomarkers for osteoporosis. PDFF and R2*MP combination might improve the prediction in differentiating healthy subjects from those with osteoporosis.
OBJECTIVE: To investigate multi-echo chemical shift-encoded MRI-based mapping of proton density fat fraction (PDFF) and fat-corrected R2* in bone marrow as biomarkers for osteoporosis assessment. METHODS: Fifty-one patients (28 female; mean age 69.7 ± 9.0 years) underwent dual energy X-ray absorptiometry (DXA). On the basis of the t score, 173 valid vertebrae bodies were divided into three groups (healthy, osteopenic and osteoporotic). Three echo chemical shift-encoded MRI sequences were acquired at 3 T. PDFF and R2* with correction for multiple-peak fat (R2*MP) were measured for each vertebral body. Kruskal-Wallis test and post hoc analysis were performed to evaluate differences between groups. Further, the area under the curve (AUC) for each technique was calculated using logistic regression analysis. RESULTS: On the basis of DXA, 92 samples were normal (53 %), 47 osteopenic (27 %) and 34 osteoporotic (20 %). PDFF was increased in osteoporosis compared with healthy (P = 0.007). R2*MP showed significant differences between normal and osteopenia (P = 0.004), and between normal and osteoporosis (P < 0.001). AUC to differentiate between normal and osteoporosis was 0.698 for R2*MP, 0.656 for PDFF and 0.74 for both combined. CONCLUSION: PDFF and R2*MP are moderate biomarkers for osteoporosis. PDFF and R2*MP combination might improve the prediction in differentiating healthy subjects from those with osteoporosis.
Authors: John Damilakis; Thomas Maris; George Papadokostakis; Liana Sideri; Nicholas Gourtsoyiannis Journal: Invest Radiol Date: 2004-11 Impact factor: 6.016
Authors: Thomas G Maris; John Damilakis; Liana Sideri; Michael Deimling; Georgios Papadokostakis; Olympia Papakonstantinou; Nikos Gourtsoyiannis Journal: Eur J Radiol Date: 2004-06 Impact factor: 3.528
Authors: Camilo A Campo; Diego Hernando; Tilman Schubert; Candice A Bookwalter; Andrew J Van Pay; Scott B Reeder Journal: AJR Am J Roentgenol Date: 2017-07-13 Impact factor: 3.959
Authors: Louis Marage; Jeremy Lasbleiz; Maxime Fondin; Mathieu Lederlin; Giulio Gambarota; Hervé Saint-Jalmes Journal: MAGMA Date: 2021-03-12 Impact factor: 2.310
Authors: Gregory Chang; Sean Boone; Dimitri Martel; Chamith S Rajapakse; Robert S Hallyburton; Mitch Valko; Stephen Honig; Ravinder R Regatte Journal: J Magn Reson Imaging Date: 2017-02-06 Impact factor: 4.813
Authors: Stefan Ruschke; Amber Pokorney; Thomas Baum; Holger Eggers; Jeffrey H Miller; Houchun H Hu; Dimitrios C Karampinos Journal: MAGMA Date: 2017-04-05 Impact factor: 2.310